This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
European Medicines Agency (EMEA).European Medicines Agency confirms positive benefit-risk balance for rosiglitazone and pioglitazone. Media Release: 18 Oct 2007. Available from: URL: http://www.emea.europa.eu
GlaxoSmirthKline.European Medicine Agency (EMEA) confirms positive Avandia benefit risk assessment. Media Release: 18 Oct 2007. Available from: URL: http://www.gsk.com
About this article
Cite this article
Positive benefit-risk balance continues for glitazones – EMEA. React. Wkly. 1175, 2 (2007). https://doi.org/10.2165/00128415-200711750-00003
- Bone Fracture
- Product Characteristic
- Ischaemic Heart Disease